New Product Launch
New Product Launch: Eptifibatide
Juno Pharmaceuticals Canada is pleased to announce the launch of our latest product, Eptifibatide for injection which is available at your local Canadian wholesalers!
Eptifibatide is used for the treatment of patients presenting with symptoms of unstable angina (UA)/non-ST-segment
elevation myocardial infarction (NSTEMI), including those patients who may subsequently undergo
percutaneous coronary intervention (PCI) as well as those who will be managed medically.
.
Juno - CPHI 2024
New Product Launch: Norepinephrine
Quality & Compliance Specialist
Regulatory Affairs Project Manager
Quality & Compliance Associate
Juno Pharmaceuticals est fier d'être partenaire avec Omega Laboratories
Juno Pharmaceuticals is proud to acquire Omega Laboratories
Juno Pharmaceuticals Canada & Rosemont Joint Partnership Announcement
New Product Launch: Bortezomib
Juno Pharmaceuticals Canada & J. Molner Joint Partnership Announcement